Sichuan Chuanhuan Technology
300547
Shenzhen Manst Technology
301325
Zhonghang Electronic Measuring Instruments
300114
Shanghai Cooltech Power
300153
Jiangsu Yitong High-tech
300211
CN Stock MarketDetailed Quotes
688658 Youcare Pharmaceutical Group
- 16.33
- +0.24+1.49%
Pre-Opening Auction Dec 27 09:30 CST
7.35BMarket Cap30.35P/E (TTM)
0.00High0.00Low0lotVolume0.00Open16.09Pre Close0.00Turnover0.00%Turnover Ratio39.73P/E (Static)450.00MShares25.3552wk High2.01P/B7.35BFloat Cap11.7952wk Low19.31Limit Up450.00MShs Float34.23Historical High12.87Limit Down0.00%Amplitude11.79Historical Low0.20Dividend TTM--Avg Price0lotAsk1.22%Div YieldTTM100Lot Size0lotBid
Youcare Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.15%2.99B | -11.36%1.95B | -14.24%967.9M | -7.61%4.2B | -15.54%2.96B | 14.05%2.2B | 25.28%1.13B | -8.53%4.54B | 4.69%3.5B | -9.50%1.93B |
| Operating revenue | 1.15%2.99B | -11.36%1.95B | -14.24%967.9M | -7.61%4.2B | -15.54%2.96B | 14.05%2.2B | 25.28%1.13B | -8.53%4.54B | 4.69%3.5B | -9.50%1.93B |
| Total operating cost | -2.06%2.73B | -8.27%1.8B | -11.91%904.07M | -5.61%3.96B | -10.74%2.79B | 10.54%1.97B | 21.94%1.03B | -2.82%4.2B | 7.05%3.12B | -5.11%1.78B |
| Operating cost | 12.37%1.19B | 9.99%813.08M | 2.95%455.92M | -2.45%1.57B | -1.81%1.05B | 21.79%739.25M | 39.05%442.87M | 5.14%1.61B | 2.10%1.07B | -9.14%607.01M |
| Operating tax surcharges | -2.89%38.4M | -14.30%24.54M | -11.41%11.73M | 0.92%54.82M | -9.61%39.54M | 30.26%28.63M | 39.31%13.24M | -14.77%54.32M | 2.87%43.75M | -18.99%21.98M |
| Operating expense | -17.26%1.08B | -29.89%679.47M | -33.77%294.03M | -10.68%1.77B | -16.67%1.3B | 12.18%969.12M | 17.35%443.94M | -14.98%1.98B | -1.10%1.56B | -15.34%863.88M |
| Administration expense | -2.43%164.33M | 9.42%109.11M | 1.66%57.43M | -6.09%230.32M | -19.61%168.43M | -28.80%99.72M | -19.53%56.5M | 5.62%245.26M | 25.94%209.53M | 25.92%140.06M |
| Financial expense | 138.94%3.54M | 111.08%943.12K | 86.41%-539.68K | 68.56%-10.27M | 68.85%-9.08M | 55.66%-8.51M | 54.88%-3.97M | 1.18%-32.68M | -27.87%-29.14M | -49.06%-19.2M |
| -Interest expense (Financial expense) | 90.73%17.19M | 101.12%11.42M | 118.48%5.54M | 181.26%13.21M | 281.41%9.01M | 391.83%5.68M | 438.86%2.53M | 35.23%4.7M | -35.78%2.36M | -66.19%1.15M |
| -Interest Income (Financial expense) | 17.59%-14.91M | 22.89%-10.25M | 5.75%-5.69M | 17.23%-23.4M | 20.55%-18.1M | 19.18%-13.29M | 28.17%-6.03M | 9.23%-28.27M | -0.23%-22.78M | -15.56%-16.45M |
| Research and development | 12.70%261.15M | 27.63%177.63M | 15.97%85.5M | 2.17%351.88M | -11.51%231.72M | -16.19%139.17M | -0.28%73.73M | 72.18%344.42M | 164.84%261.85M | 169.77%166.05M |
| Credit Impairment Loss | -76.12%4.48M | -14.43%7.12M | 15.82%3.42M | 163.50%13.73M | 182.29%18.76M | 1,021.47%8.32M | -33.10%2.95M | -12.55%-21.62M | -558.21%-22.79M | 135.05%741.78K |
| Asset Impairment Loss | 10.54%-34.17M | -9.38%-20.45M | 144.60%6.33M | -19.93%-62.41M | -256.04%-38.2M | -16.92%-18.7M | -127.13%-14.2M | -27.01%-52.03M | 55.15%-10.73M | 19.58%-15.99M |
| Other net revenue | ||||||||||
| Fair value change income | ---- | ---- | ---- | -123.74%-686.88K | ---- | ---- | ---- | --2.89M | ---- | ---- |
| Invest income | ---- | ---- | ---- | -129.54%-320.7K | ---330.84K | ---160.88K | ---- | -73.09%1.09M | ---- | ---- |
| Asset deal income | -97.11%29.44K | -82.05%205.25K | -100.05%-606.84 | 2,441.45%1.04M | 2,359.73%1.02M | 2,662.38%1.14M | 2,662.38%1.14M | 295.50%41.05K | 488.04%41.4K | 388.18%41.4K |
| Other revenue | 8.80%22.92M | 7.31%12.55M | 63.25%6.78M | -45.31%44.42M | -39.49%21.06M | -28.38%11.7M | -39.73%4.15M | 81.81%81.24M | 33.36%34.81M | 110.21%16.33M |
| Operating profit | 47.84%254.97M | -38.39%144.7M | -16.55%80.36M | -35.25%231.75M | -54.68%172.46M | 56.29%234.85M | 49.78%96.31M | -43.79%357.94M | -11.53%380.54M | -37.92%150.26M |
| Add:Non operating Income | 48.80%2.17M | 91.39%1.55M | 870.28%372.2K | -59.42%2.01M | -69.03%1.46M | -80.53%812.1K | -93.84%38.36K | 165.51%4.94M | 286.01%4.7M | 443.26%4.17M |
| Less:Non operating expense | 8.72%8.87M | 18.52%7.71M | -47.77%1.62M | -21.47%10.49M | 210.96%8.16M | 814.79%6.51M | 548.16%3.1M | 41.91%13.36M | -64.93%2.62M | -86.71%711.21K |
| Total profit | 49.78%248.27M | -39.54%138.54M | -15.15%79.12M | -36.12%223.27M | -56.68%165.76M | 49.07%229.15M | 44.68%93.24M | -44.46%349.53M | -9.73%382.62M | -35.27%153.72M |
| Less:Income tax cost | 259.80%40.07M | 0.37%20.59M | 29.60%9.99M | 236.87%35.77M | -75.16%11.14M | 78.02%20.52M | 1,524.19%7.71M | -87.59%10.62M | -12.81%44.83M | -53.68%11.53M |
| Net profit | 34.65%208.2M | -43.47%117.95M | -19.18%69.12M | -44.68%187.49M | -54.22%154.62M | 46.72%208.63M | 33.71%85.53M | -37.67%338.91M | -9.30%337.78M | -33.11%142.2M |
| Net profit from continuing operation | 34.65%208.2M | -43.47%117.95M | -19.18%69.12M | -44.68%187.49M | -54.22%154.62M | 46.72%208.63M | 33.71%85.53M | -37.67%338.91M | -9.30%337.78M | -33.11%142.2M |
| Less:Minority Profit | -164.89%-1.52M | -139.04%-607.72K | -168.28%-181.14K | -27.49%2.7M | 3.09%2.35M | -17.96%1.56M | -47.31%265.28K | 333.59%3.72M | 306.28%2.28M | 648.77%1.9M |
| Net profit of parent company owners | 37.73%209.73M | -42.75%118.55M | -18.72%69.31M | -44.87%184.8M | -54.61%152.27M | 47.60%207.08M | 34.35%85.27M | -38.53%335.18M | -10.18%335.5M | -34.11%140.3M |
| Earning per share | ||||||||||
| Basic earning per share | 38.24%0.47 | -43.48%0.26 | -21.05%0.15 | -44.59%0.41 | -54.67%0.34 | 48.39%0.46 | 35.71%0.19 | -38.84%0.74 | -9.64%0.75 | -34.04%0.31 |
| Diluted earning per share | 38.24%0.47 | -43.48%0.26 | -21.05%0.15 | -44.59%0.41 | -54.67%0.34 | 48.39%0.46 | 35.71%0.19 | -38.84%0.74 | -9.64%0.75 | -34.04%0.31 |
| Other composite income | ||||||||||
| Total composite income | 34.65%208.2M | -43.47%117.95M | -19.18%69.12M | -44.68%187.49M | -54.22%154.62M | 46.72%208.63M | 33.71%85.53M | -37.67%338.91M | -9.30%337.78M | -33.11%142.2M |
| Total composite income of parent company owners | 37.73%209.73M | -42.75%118.55M | -18.72%69.31M | -44.87%184.8M | -54.61%152.27M | 47.60%207.08M | 34.35%85.27M | -38.53%335.18M | -10.18%335.5M | -34.11%140.3M |
| Total composite income of minority owners | -164.89%-1.52M | -139.04%-607.72K | -168.28%-181.14K | -27.49%2.7M | 3.09%2.35M | -17.96%1.56M | -47.31%265.28K | 333.59%3.72M | 306.28%2.28M | 648.77%1.9M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.